By Ernie Mundell HealthDay Reporter
FRIDAY, Oct. 11, 2024 (HealthDay News) -- Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out...
No serious adverse events seen with either treatment in eight-week crossover trial,
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy PolicyOk